VIQUgim-1-Forte
Description_Effects
VIQUgim-1-Forte (Glimepiride 1mg + Metformin 1000mg PR) is a combination medicine used to manage type 2 diabetes mellitus in adults. It combines two antidiabetic agents that work through different mechanisms to effectively lower blood sugar levels. Glimepiride belongs to the sulfonylurea class and stimulates the pancreas to produce more insulin. Metformin, a biguanide, works by reducing the liver’s glucose production, slowing intestinal glucose absorption, and improving the body’s sensitivity to insulin. This tablet is typically taken once daily with food, ideally with the first main meal of the day, to reduce the risk of gastrointestinal side effects and ensure maximum effectiveness. The "PR" (prolonged-release) formulation allows the medicine to be released slowly, providing steady blood glucose control over an extended period and improving treatment tolerance. Controlling blood sugar is crucial in preventing serious diabetes-related complications such as kidney damage, vision problems, nerve damage, and even limb loss. VIQUgim-1-Forte helps reduce these risks when used as part of a broader diabetes management plan that includes a healthy diet, regular exercise, and routine glucose monitoring. To get the most benefit, take this medication consistently as prescribed. Never adjust the dose on your own without consulting your doctor, and attend all follow-up appointments to track your progress.
